B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy

Cell

Volumn 80, Issue 5, 1995, Pages 707-718

  Kuchroo, Vijay K ^a   Prabhu Das, Mercy ^a   Brown, Julia A ^b   Ranger, Ann M ^c   Zamvil, Scott S ^a   Sobel, Raymond A ^c   Weiner, Howard L ^a   Nabavi, Nasrin ^d   Glimcher, Laurie H ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Department of Inflammation Autoimmune Disease Hoff mann La Roche Research Center Nutley ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 4 ANTIBODY; LYMPHOCYTE ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY B7 1; MONOCLONAL ANTIBODY B7 2; MYELIN BASIC PROTEIN; PROTEOLIPID PROTEIN; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; BRAIN; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HELPER CELL; HISTOPATHOLOGY; IMMUNIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LYMPH NODE CELL; LYMPHOCYTE CLONE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD; SPLEEN CELL; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

AMINO ACID SEQUENCE; ANIMAL; ANTIBODIES, MONOCLONAL; ANTIGENS, CD80; CELL DIFFERENTIATION; CELLS, CULTURED; ENCEPHALOMYELITIS, EXPERIMENTAL AUTOIMMUNE; FEMALE; IMMUNOTHERAPY, ADOPTIVE; INTERFERON TYPE II; INTERLEUKIN-4; LYMPH NODES; MEMBRANE GLYCOPROTEINS; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; MYELIN BASIC PROTEINS; PROTEOLIPIDS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TH1 CELLS; TH2 CELLS; VACCINATION;

EID: 0028949152     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/0092-8674(95)90349-6     Document Type: Article

References (45)

1. B70 antigen is a second ligand for CTLA-4 and CD28
2. Surface expression of a4 integrin by CD4 T cells is required for their entry into brain parenchyma
3. +tumor cells are potent vaccines for stimulating tumor rejection in tumor-bearing mice
4. In vitro induction of T cell anergy by blocking B7 and early T cell costimulatory molecule ETC-1/B7-2
5. Monoclonal antibody 2D10 recognizes a novel T cell costimulatory molecule on activated murine B lymphocytes
6. Contimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4
7. Regulatory T cell clones induced by oral tolerance and suppression of autoimmune encephalomyelitis
8. T cell shift: key to AIDS therapy?
9. Treatment of murine lupus with CTLA4Ig
10. Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7
11. Uncovering of functional alternative CTLA-4 counter-receptor in 87-deficient mice
12. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation
13. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity
14. The role of the T cell costimulator B7-1 in autoimmunity and the induction and maintenance of tolerance to peripheral antigen
15. CD28-mediated signalling co-stimulates murine T cells and prevents induction of energy in T-cell clones
16. Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function
17. Reciprocal expression of interferon y or interleukin 4 during the resolution or progression of murine leishmaniasis: evidence for expansion of distinct helper T cell subsets
18. + T cells in murine experimental allergic encephalomyelitis
19. Oral tolerance to myelin basic protein and natural recovery from experimental allergic encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor-β, interleukin 4, and prostaglandin E expression in the brain
20. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis
21. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice
22. The structure of bovine myelin proteolipid and its organization in myelin
23. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig
24. CTLA-4 is a second receptor for the B cell activation antigen B7
25. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule
26. Human B7-2 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors
27. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties
28. Signalling through the MHC class 11 cytoplasmic domain is required for antigen presentation and induces B7 expression
29. Identification of cDNA coding for a fifth form of myelin basic protein
30. ras
31. Lymphocyte responses and cytokines
32. Cytokine regulation of T-cell function: potential for therapeutic intervention
33. T-cell antigen CD28 interacts with the lipid kinase phosphatidylinositol 3-kinase by a cytoplasmic Tyr(P)-Met-Xaa-Met motif
34. Expression and function of the murine B7 antigen, the major costimulatory molecule expressed by peritoneal exudate cells
35. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in IL-2 production and immunotherapy
36. + T cells
37. Divergent T-cell cytokine patterns in inflammatory arthritis
38. Acute allergic encephalomyelitis in SJL/J mice induced by a synthetic peptide of myelin proteolipid protein
39. + T cells by B7-transfected melanoma cells
40. Interleukin-12 and its role in the generation of Th1 cells
41. Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice
42. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo
43. CTLA-4 can function as a negative regulator of T cell activation
44. pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3
45. The T lymphocyte in experimental allergic encephalomyelitis